(BOLD) Audentes Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Audentes Therapeutics | (BOLD) share price targets
Complete technical analysis of Audentes Therapeutics (BOLD) by charts plus indicators, forecast predictions and share price targets for Audentes Therapeutics (BOLD)
Audentes Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-11-14 View latest technical analysis
10 day averaged volume of Audentes Therapeutics is 77690
| Date | Daily Closing Price | Open | High | Low | Volume |
| 14 Fri Nov 2025 | 1.24 | 1.18 | 1.26 | 1.17 | 1.027 times |
| 13 Thu Nov 2025 | 1.20 | 1.25 | 1.25 | 1.19 | 0.396 times |
| 12 Wed Nov 2025 | 1.23 | 1.25 | 1.26 | 1.19 | 0.569 times |
| 11 Tue Nov 2025 | 1.26 | 1.22 | 1.28 | 1.22 | 1.207 times |
| 10 Mon Nov 2025 | 1.21 | 1.22 | 1.23 | 1.18 | 0.573 times |
| 07 Fri Nov 2025 | 1.23 | 1.24 | 1.25 | 1.15 | 2.312 times |
| 06 Thu Nov 2025 | 1.26 | 1.30 | 1.30 | 1.23 | 0.551 times |
| 05 Wed Nov 2025 | 1.26 | 1.26 | 1.30 | 1.25 | 0.622 times |
| 04 Tue Nov 2025 | 1.30 | 1.35 | 1.36 | 1.28 | 0.822 times |
| 31 Fri Oct 2025 | 1.40 | 1.38 | 1.40 | 1.36 | 1.474 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1.2 as stoploss in an intra day buy trade for a target of 1.35. However, stock will show a bearish move below 1.2.
Share price targets for Audentes Therapeutics (BOLD)
| Target Type | Value |
| Downside Target | 1.02 |
| Downside Target | 1.05 |
| Downside Target | 1.10 |
| Downside Target | 1.15 |
| Downside Target | 1.20 |
| Upside Target | 1.26 |
| Upside Target | 1.32 |
| Upside Target | 1.36 |
| Upside Target | 1.37 |
| Upside Target | 1.40 |
| Upside Target | 1.52 |
| Upside Target | 1.55 |
Intraday share price targets for Audentes Therapeutics (BOLD)
| Target Type | Value |
| Downside Intraday Target | 1.18 |
| Downside Intraday Target | 1.12 |
| Upside Intraday Target | 1.29 |
| Upside Intraday Target | 1.34 |
| Downside Intraday Target | 1.23 |
Weekly technical analysis of Audentes Therapeutics (BOLD)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 14 Fri Nov 2025 | 1.24 | 1.22 | 1.28 | 1.17 | 0.876 times |
| 07 Fri Nov 2025 | 1.23 | 1.35 | 1.36 | 1.15 | 2.922 times |
| 31 Fri Oct 2025 | 1.40 | 1.38 | 1.40 | 1.36 | 0.291 times |
| 31 Fri Oct 2025 | 1.40 | 1.47 | 1.52 | 1.36 | 0.432 times |
| 24 Fri Oct 2025 | 1.46 | 1.37 | 1.55 | 1.37 | 0.707 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Audentes Therapeutics (BOLD)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 14 Fri Nov 2025 | 1.24 | 1.35 | 1.36 | 1.15 | 0.158 times |
| 31 Fri Oct 2025 | 1.40 | 1.24 | 1.55 | 1.20 | 1.85 times |
| 30 Tue Sep 2025 | 1.23 | 1.12 | 1.26 | 1.10 | 1.447 times |
| 29 Fri Aug 2025 | 1.12 | 1.20 | 1.20 | 1.05 | 0.653 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Audentes Therapeutics (BOLD)
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Audentes Therapeutics in short term and the sell signal is strong.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Audentes Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Audentes Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.27 and Audentes Therapeutics (BOLD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics (BOLD) stock. Volume based technical analysis of Audentes Therapeutics (BOLD) stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Audentes Therapeutics in short term and the sell signal is strong.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Audentes Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Audentes Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.27 and Audentes Therapeutics (BOLD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics (BOLD) stock. Volume based technical analysis of Audentes Therapeutics (BOLD) stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.